Oxygen therapy for dyspnoea in adults

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 11, 2013, Pages

  Cranston, Josephine M ^a   Crockett, Alan ^b   Currow, David ^c   Ekström, Magnus ^d,e   Abernethy, A ^f  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d LUND UNIVERSITY   (Sweden)

^e BLEKINGE HOSPITAL   (Sweden)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRIORITY JOURNAL; RETRACTED ARTICLE; REVIEW; ADULT; DYSPNEA; HUMAN; META ANALYSIS; METHODOLOGY; OXYGEN THERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; DYSPNEA; HUMANS; OXYGEN INHALATION THERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84900765954     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004769.pub3     Document Type: Review

References (37)

1. Ahmedzai SH, Laude E, Robertson A, Troy G, Vora V. A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion. British Journal of Cancer 2004;90:366-71.
2. Booth S, Kelly MJ, Cox NP, Adams L, Guz A. Does oxygen help dyspnea in patients with cancer?. American Journal of Respiratory and Critical Care Medicine 1996;153:1515-8.
3. Bruera E, de Stoutz N, Velasco-Leiva A, Schoeller T, Hanson J. Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients. Lancet 1993;342(8862):13-4.
4. Bruera E, Sweeney C, Willey J, Palmer JL, Strasser F, Morice RC, et al. A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea. Palliative Medicine 2003;17:659-63.
5. Chua TP, Ponikowski PP, Harrington D, Chambers J, Coats AJ. Contribution of peripheral chemoreceptors to ventilation and the effects of their suppression on exercise tolerance in chronic heart failure. Heart 1996;76(6):483-9.
6. Meecham Jones DJ, Paul EA, Bell JH, Wedzicha JA. Ambulatory oxygen therapy in stable kyphoscoliosis. European Respiratory Journal 1995;8(5):819-23.
7. Moore DP, Weston AR, Hughes JM, Oakley CM, Cleland JG. Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure. Lancet 1992;339(8797):184-5.
8. Restrick LJ, Davies SW, Noone L, Wedzicha JA. Ambulatory oxygen in chronic heart failure. Lancet 1992;340(8829):1192-3.
9. Bruera E, Schoeller T, MacEachern T. Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: the use of the N of 1 randomized controlled trial. Journal of Pain and Symptom Management 1992;7(6):365-8.
10. Navigante AH, Cerchietti LCA, Cabalar ME. Morphine plus midazolam versus oxygen therapy on severe dyspnoea management in the last week of life in hypoxemic advanced cancer patients [Morfina mas midazolan versus oxigenoterapia en el control de la disnea severa durante la ultima semana de vida en pacientes hipoxemicos con cancer avanzado]. Medicina Paliativa 2003;10(1):14-9.
11. Russell SD, Koshkarian GM, Medinger AE, Carson PE, Higginbotham MB. Lack of effect of increased inspired oxygen concentrations on maximal exercise capacity or ventilation in stable heart failure. American Journal of Cardiology 1999;84(12):1412-6.
12. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine 2002;166:111-7.
13. American Thoracic Society, American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. American Journal of Respiratory and Critical Care Medicine 2003;167(2):1451-2.
14. Bausewein C, Booth S, Gysels M, Higginson I. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database of Systematic Reviews 2008, Issue 2.
15. Beckles MA, Spiro SG, Colice GL, Rudd RM. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest 2003;123(1 Suppl):105S-14S.
16. Bernardi L, Spadacini G, Bellwon J, Hajric R, Roskamm H, Frey AW. Effect of breathing rate on oxygen saturation and exercise performance in chronic heart failure. Lancet 1998;351(9112):1308-11.
17. Booth S, Wade R. Oxygen or air for palliation of breathlessness in advanced cancer. Journal of the Royal Society of Medicine 2003;96:215-8.
18. Booth S, Wade R, Johnson M, Kite S, Swannick M, Anderson H, Expert Working Group of the Scientific Committee of the Association of Palliative Medicine. The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respiratory Medicine 2004;98:66-77.
19. Borg GA. Psychophysical bases of perceived exertion. Medicine and Science in Sports and Exercise 1982;14(5):377-81.
20. Bradley JM, O'Neill B. Short term ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2005, Issue 2.
21. Brostrom A, Hubbert L, Jakobsson P, Johansson P, Fridlund B, Dahlstrom U. Effects of long-term nocturnal oxygen treatment in patients with severe heart failure. Journal of Cardiovascular Nursing 2005;20(6):385-96.
22. Casaburi R, Porszasz J. Reduction of hyperinflation by pharmacologic and other interventions. Proceedings of the American Thoracic Society 2006;3:185-9.
23. Gallagher R, Roberts D. A systematic review of oxygen and airflow effect on relief of dyspnea at rest in patients with advanced disease of any cause. Journal of Pain & Palliative Care Pharmacotherapy 2004;18(4):3-15.
24. Grant S, McMurray J, Aitchison T, McDonagh T, Christie J, Davie A, et al. The reproducibility of symptoms during a submaximal exercise test in chronic heart failure. British Journal of Clinical Pharmacology 1998;45(3):287-90.
25. Haque WA, Boehmer J, Clemson BS, Leuenberger UA, Silber DH, Sinoway LI. Hemodynamic effects of supplemental oxygen administration in congestive heart failure. Journal of the American College of Cardiology 1996;27(2):353-7.
26. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated September 2006]. In: The Cochrane Library. Chichester, UK: Wiley-Blackwell, 2005, issue Issue 3:Chapter 8.
27. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
28. Jennings AL, Davies AN, Higgins JPT, Broadley K. Opioids for the palliation of breathlessness in terminal illness. Cochrane Database of Systematic Reviews 2001, Issue 3.
29. Liss HP, Grant BJ. The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. American Review of Respiratory Disease 1988;137(6):1285-8.
30. McDonald CF, Crockett AJ, Young IH. Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand. The Medical Journal of Australia 2005;183(3):621-6.
31. O'Donnell DE, D'Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2001;163:892-8.
32. Olsson LG, Swedberg K, Clark AL, Witte KK, Cleland JGF. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. European Heart Journal 2005;26(8):778-93.
33. Ram FSF, Wedzicha JA. Ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2002, Issue 1. [Art. No.: CD000238]
34. Sasayama S, Izumi T, Seino Y, Ueshima K, Asanoi H and for The CHF-HOT Study Group. Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and Cheyne-Stokes respiration. Circulation Journal 2006;70(1):1-7.
35. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 1995;273(5):408-12.
36. Wilcock A, Crosby V, Clarke D, Tattersfield A. Repeatability of breathlessness measurements in cancer patients. Thorax 1999;54(4):375.
37. Zeppetella G. The palliation of dyspnea in terminal disease. American Journal of Hospice and Palliative Care 1998;15(6):322-30.